Results 61 to 70 of about 4,777,622 (429)

Comparison of Survival Status and Related Risk Factors of Esophageal Squamous Cell Carcinoma Patients Between High- and Low-incidence Areas of ESCC

Zhongliu Fangzhi Yanjiu, 2019
Objective To compare the survival condition and related risk factors of the patients with ESCC between high-incidence area (HIA) and low-incidence area (LIA) of ESCC.
HU Shoujia, FAN Zongmin, YUE Wenbin, CHEN Peinan, LI Xiumin, LI Jilin, HAN Shaohua, WANG Wei, YIN Yanchun, SONG Xin, ZHAO Xueke, WANG Jianpo, WANG Lidong   +12 more
doaj   +1 more source

Suppression of esophageal tumor growth and chemoresistance by directly targeting the PI3K/AKT pathway [PDF]

, 2014
Esophageal cancer is the sixth most common cause of cancer-related deaths worldwide. Novel therapeutic intervention is urgently needed for this deadly disease. The functional role of PI3K/AKT pathway in esophageal cancer is little known.
Cheung, ALM, Guan, XY, Law, SYK, Li, B, Li, J, Qin, YR, Tsao, GSW, Xu, WW, Zhang, LY   +8 more
core   +1 more source

Understanding Esophageal Cancer: The Challenges and Opportunities for the Next Decade

Frontiers in Oncology, 2020
Esophageal cancer (EC) is the seventh most common cancer worldwide with over 570,000 new cases annually. In China, the incidence of EC is particularly high where approximately 90% of cases are defined as esophageal squamous cell carcinoma (ESCC ...
Jianjun Yang, Xiguang Liu, S. Cao, Xiaoying Dong, Shuan Rao, K. Cai   +5 more
semanticscholar   +1 more source

Clinical significance of VEGF-A, -C and -D expression in esophageal malignancies [PDF]

, 2005
Vascular endothelial growth factors ( VEGF)- A, - C and - D are members of the proangiogenic VEGF family of glycoproteins. VEGF-A is known to be the most important angiogenic factor under physiological and pathological conditions, while VEGF-C and VEGF-D
Ahn MJ, Baatar D, Banks RE, Berse B, Boucher Y, Coia LR, Dirix LY, Du JR, Gu ZP, Guo WZ, Hefler L, Hickey K, Hironaka S, Isaka N, Ishikawa M, Karpanen T, Kato H, Kitadai Y, Kitamura K, Koide N, Koukourakis MI, Kukk E, Kumar H, Lackey VL, Lewis CE, Li Z, Maniwa Y, Millikan KW, Mobius C, Nagata J, Nguyen M, Noguchi T, Nor JE, Ohtsu A, Roberts WG, Rockwell S, Roder JD, Salven P, Shih CH, Spence GM, Suit HD, Theunissen PH, Uchida S, Vogel SB, Wallner G, Weingartner K, Yamamoto Y, Yang B, Yeo KT   +48 more
core   +1 more source

HIV infection and domestic smoke exposure, but not human papillomavirus, are risk factors for esophageal squamous cell carcinoma in Zambia: a case-control study [PDF]

, 2015
(c) 2015 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original ...
Asombang, AW, Banda, T, Bateman, AC, Kayamba, V, Kelly, P, Shibemba, A, Soko, R, Zyambo, K   +7 more
core   +2 more sources

Trends in the incidence and survival of patients with esophageal cancer: A SEER database analysis

Thoracic Cancer, 2020
Recent studies have indicated that the incidence of esophageal cancer has declined in the past decade in the U.S. However, trends in the incidence and survival have not been thoroughly examined.
Haiqi He, Nanzheng Chen, Y. Hou, Zhe Wang, Yong Zhang, Guang-jian Zhang, Junke Fu   +6 more
semanticscholar   +1 more source

The alterations of cytokeratin and vimentin protein expressions in primary esophageal spindle cell carcinoma

BMC Cancer, 2018
Background The accumulated evidence has indicated the diagnostic role of cytokeratin (CK) and vimentin protein immunoassay in primary esophageal spindle cell carcinoma (PESC), which is a rare malignant tumor with epithelial and spindle components ...
Xin Min Li, Xin Song, Xue Ke Zhao, Shou Jia Hu, Rang Cheng, Shuang Lv, Dan Feng Du, Xiang Yang Zhang, Jian Liang Lu, Jian Wei Ku, Dong Yun Zhang, Yao Zhang, Zong Min Fan, Li Dong Wang   +13 more
doaj   +1 more source

Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer

New England Journal of Medicine, 2019
BACKGROUND Postoperative complications, especially pulmonary complications, affect more than half the patients who undergo open esophagectomy for esophageal cancer.
C. Mariette, S. Markar, T. S. Dabakuyo-Yonli, B. Meunier, D. Pezet, D. Collet, X. D’Journo, C. Brigand, T. Perniceni, N. Carrère, J. Mabrut, S. Msika, F. Peschaud, M. Prudhomme, F. Bonnetain, G. Piessen   +15 more
semanticscholar   +1 more source

Global trends in the incidence and mortality of esophageal cancer from 1990 to 2017

Cancer Medicine, 2020
The incidence and mortality of esophageal cancer are high, with 5.90 new cases and 5.48 deaths per 100 000 people worldwide in 2017. The prognosis of esophageal cancer is poor, with an overall 5‐year survival rate of less than 20%.
Jiahui Fan, Zhenqiu Liu, Xianhua Mao, Xin Tong, Tiejun Zhang, C. Suo, Xingdong Chen   +6 more
semanticscholar   +1 more source

Lymphangiography and focal pleurodesis treatment of chylothorax with an aberrant thoracic duct following oesophagectomy: a case report

Surgical Case Reports, 2019
Background Management of postoperative chylothorax usually consists of nutritional regimens, pharmacological therapies such as octreotide, and surgical therapies such as ligation of thoracic duct, but a clear consensus is yet to be reached.
Tomoyuki Ishida, Jun Kanamori, Hiroyuki Daiko   +2 more
doaj   +1 more source